{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:59:15Z","timestamp":1764997155808},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jpeds.2017.10.011","type":"journal-article","created":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T09:21:56Z","timestamp":1516785716000},"page":"102-108.e1","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Obese Children Require Lower Doses of Pantoprazole Than Nonobese Peers to Achieve Equal Systemic Drug Exposures"],"prefix":"10.1016","volume":"193","author":[{"given":"Valentina","family":"Shakhnovich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Brian","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey T.","family":"Guptill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura P.","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David N.","family":"Collier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huali","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad E.","family":"Livingston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory L.","family":"Kearns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Daniel K.","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine Y.","family":"Berezny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Michael Cohen","family":"Wolkowiez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew M.","family":"Laughon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian M.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"van den Anker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Wade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perdita","family":"Taylor-Zapata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Zajicek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoxia","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterini","family":"Tsilou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Pagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravinder","family":"Anand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Traci","family":"Clemons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina","family":"Simone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaylene","family":"Weigel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Darden Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2017.10.011_bib0010","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/jama.2014.732","article-title":"Prevalence of childhood and adult obesity in the United States, 2011-2012","volume":"311","author":"Ogden","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0015","first-page":"6","article-title":"Prevalence of childhood and adult obesity in the United States","volume":"311","author":"Ogden","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.amjsurg.2004.06.038","article-title":"Weight loss and improvement of obesity-related illness in 500 US patients following laparoscopic adjustable gastric banding procedure","volume":"189","author":"Spivak","year":"2005","journal-title":"Am J Surg"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0025","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/j.1572-0241.2005.41703.x","article-title":"Obesity is an independent risk factor for GERD symptoms and erosive esophagitis","volume":"100","author":"El-Serag","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0030","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/jamapediatrics.2015.132","article-title":"Drug dosing in obese children: a systematic review of current pharmacokinetic data","volume":"169","author":"Harskamp-van Ginkel","year":"2015","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0035","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.clinthera.2015.08.006","article-title":"Gaps in drug dosing for obese children: a systematic review of the commonly prescribed acute care medications","volume":"37","author":"Rowe","year":"2015","journal-title":"Clin Ther"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0040","doi-asserted-by":"crossref","DOI":"10.3109\/17477166.2010.491118","article-title":"Extreme childhood obesity is associated with increased risk for gastroesophageal reflux disease in a large population-based study","volume":"6","author":"Koebnick","year":"2011","journal-title":"Int J Pediatr Obes"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00128072-200305010-00003","article-title":"The use of proton pump inhibitors in children: a comprehensive review","volume":"5","author":"Gibbons","year":"2003","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1542\/peds.2011-2879","article-title":"Trends of outpatient prescription drug utilization in US children, 2002-2010","volume":"130","author":"Chai","year":"2012","journal-title":"Pediatrics"},{"author":"Centers for Disease Control and Prevention\/National Center for Health Statistics","key":"10.1016\/j.jpeds.2017.10.011_bib0055"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0060","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/ajg.2009.632","article-title":"Double-dosed pantoprazole accelerates the sustained symptomatic response in overweight and obese patients with reflux esophagitis in Los Angeles grades A and B","volume":"105","author":"Chen","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0065","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.bone.2010.12.015","article-title":"Meta-analysis: risk of fractures with acid-suppressing medications","volume":"48","author":"Kwok","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0070","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00198-015-3168-0","article-title":"Use of proton pump inhibitors is associated with fractures in young adults: a population-based study","volume":"26","author":"Freedberg","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0075","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jpeds.2015.08.064","article-title":"Side effects and complications of proton pump inhibitors: a pediatric perspective","volume":"168","author":"Stark","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0080","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1542\/hpeds.2012-0077","article-title":"Are there risks associated with empiric acid suppression treatment of infants and children suspected of having gastroesophageal reflux disease?","volume":"3","author":"Chung","year":"2013","journal-title":"Hosp Pediatr"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5056\/jnm.2013.19.1.25","article-title":"Pharmacokinetics and pharmacodynamics of the proton pump inhibitors","volume":"19","author":"Shin","year":"2013","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0090","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40272-013-0012-x","article-title":"Proton pump inhibitors in pediatrics","volume":"15","author":"Ward","year":"2013","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0095","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1177\/0091270008321811","article-title":"Single-dose pharmacokinetics of oral and intravenous pantoprazole in children and adolescents","volume":"48","author":"Kearns","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0100","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1124\/dmd.109.030601","article-title":"Impact of the CYP2C19*17 allele on the pharmacokinetics of omeprazole and pantoprazole in children: evidence for a differential effect","volume":"38","author":"Kearns","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0105","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1097\/00005176-200311001-00011","article-title":"Proton pump inhibitors in pediatrics: relevant pharmacokinetics and pharmacodynamics","volume":"37","author":"Kearns","year":"2003","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0110","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1753-4887.1991.tb03013.x","article-title":"The meaning and measurement of lean body mass","volume":"49","author":"Roubenoff","year":"1991","journal-title":"Nutr Rev"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0115","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1177\/0091270010377501","article-title":"A multicenter, randomized, open-label, pharmacokinetics and safety study of pantoprazole tablets in children and adolescents aged 6 through 16 years with gastroesophageal reflux disease","volume":"51","author":"Ward","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0120","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2165\/00003088-200544100-00004","article-title":"Quantification of lean bodyweight","volume":"44","author":"Janmahasatian","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0125","first-page":"99","article-title":"Lean body mass in obesity","volume":"7","author":"Forbes","year":"1983","journal-title":"Int J Obes"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0130","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/11599410-000000000-00000","article-title":"Impact of obesity on drug metabolism and elimination in adults and children","volume":"51","author":"Brill","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0135","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev-pharmtox-010814-124354","article-title":"Drug disposition in obesity: toward evidence-based dosing","volume":"55","author":"Knibbe","year":"2015","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0140","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2125.2008.03328.x","article-title":"Population pharmacokinetics of intravenous pantoprazole in paediatric intensive care patients","volume":"67","author":"Pettersen","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0145","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2165\/00003088-200544050-00001","article-title":"Pharmacokinetics of proton pump inhibitors in children","volume":"44","author":"Litalien","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0150","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1111\/j.1572-0241.2000.03256.x","article-title":"Pharmacokinetics of orally administered omeprazole in children","volume":"95","author":"Andersson","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0155","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.clinthera.2006.11.012","article-title":"Pharmacokinetic properties of esomeprazole in children aged 1 to 11 years with symptoms of gastroesophageal reflux disease: a randomized, open-label study","volume":"28","author":"Zhao","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0160","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s40262-015-0277-z","article-title":"Prediction of fat-free mass in children","volume":"54","author":"Al-Salami","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0165","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF03189822","article-title":"Comparative pharmacokinetics\/pharmacodynamic analysis of proton pump inhibitors omeprazole, lansoprazle, and pantoprazole, in humans","volume":"23","author":"Katashima","year":"1998","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.jpeds.2017.10.011_bib0170","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1002\/phar.1192","article-title":"Pharmacokinetics of intravenous voriconazole in obese patients: implications of CYP2C19 homozygous poor metabolizer genotype","volume":"33","author":"Moriyama","year":"2013","journal-title":"Pharmacotherapy"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347617313525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347617313525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T16:59:55Z","timestamp":1535129995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347617313525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":33,"alternative-id":["S0022347617313525"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2017.10.011","relation":{},"ISSN":["0022-3476"],"issn-type":[{"type":"print","value":"0022-3476"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obese Children Require Lower Doses of Pantoprazole Than Nonobese Peers to Achieve Equal Systemic Drug Exposures","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2017.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}